Ropes & Gray represented Solarea Bio, a clinical stage biotechnology developing food-derived microbial-based solutions to aid human health, in a first closing of $15 million in a Series B financing led by S2G Ventures with continued participation of Bold Capital Partners, Viking Global Investors, and GG 1978 SICAF SIF. A total of up to $25 million is targeted for this round of financing. The funds will be allocated to the commercial launch of two medical foods designed for the dietary management of bone health and rheumatoid arthritis, respectively. The financing was announced on May 8.
The Ropes & Gray team was led by venture capital & emerging companies partner Brad Flint and venture capital & emerging companies associate Joe Muller.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.